Scientific Director at Covance
Tuc is Scientific Director in the Covance Diagnostic Development team and based in Europe. He has responsibility as the primary scientific contact for Biopharma clients for initial engagement on new biomarker programs focused on discovery to provide a better understanding of therapeutic targets, molecular signaling, drug biology and patient response. His role encompasses projects at all stages of the drug development lifecycle from early exploratory research and validation to clinical trial implementation and CDx development. Tuc is part of the integrated CDx team that enables the progressive development of candidate biomarkers into research-appropriate tests and market-ready companion diagnostics aligned with drug development milestones.
Title: The Role of Effective Partnerships in Delivering a Biomarker/Companion Diagnostic Strategy
- The operational, regulatory and commercial needs of partnerships in developing and implementing a biomarker and/or CDx strategy
- The global requirements and needs for biomarker and CDx development and commercialization
- Case study: Using Immuno-Oncology biomarkers for development of effective partnerships